The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
The Epidemiology, Management, and the Associated Burden of Mental Health, Atopic and Autoimmune Conditions, and Common Infections in Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- No phase declared
- Sponsor
- Momentum Data
- Participants (registry)
- 51955
- Start
- October 2020
- Primary completion
- March 2022
- Study completion
- November 2022
- Last registry update
- December 2022
- Countries
- United Kingdom
Conditions studied: Alopecia Areata, Depressive Episode, Recurrent Depressive Disorder, Anxiety Disorders, Atopic Dermatitis, Allergic Rhinitis, Asthma, Crohn Disease, Ulcerative Colitis, Pernicious Anemia, Type 1 Diabetes, Hashimoto Thyroiditis, Graves Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus, Polymyalgia Rheumatica, Sjogren's Syndrome, Psoriasis, Vitiligo, Multiple Sclerosis, Celiac Disease, Upper Respiratory Tract Infection, Influenza, Lower Resp Tract Infection, Acute Bronchitis, Pneumonia, Gastrointestinal Infection, Skin Infection, Urinary Tract Infections, Genital Infection, Herpes Zoster, Herpes Simplex, Infection, Infection Viral
Interventions: Exposure of interest (studies 2 & 3).
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.